Healthcare Services Group (HCSG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Jul, 2026Executive summary
Full-year revenue reached $1.84 billion, up 7.1% year-over-year, with Q4 revenue at $466.7 million, up 6.6% from the prior year.
Net income for the year was $59.1 million ($0.81 EPS), and $31.2 million ($0.44 EPS) for Q4, both including an $8.3 million ($0.12/share) tax benefit from ERC receipts.
Cash flow from operations totaled $145.0 million for the year and $17.4 million for Q4; adjusted for payroll accrual, $164.1 million and $36.4 million, respectively.
Campus division achieved a milestone with over $100 million in revenue, and cost management remained within targeted ranges.
Over $60 million was returned to shareholders via share repurchases, and the balance sheet ended the year strong.
Financial highlights
Environmental Services segment revenue was $210.8 million with a 12.6% margin; Dietary Services revenue was $255.9 million with a 7.2% margin in Q4.
Cost of services for Q4 was $394.6 million (84.6% of revenue), benefiting from operational efficiencies and lower bad debt.
SG&A was $46.2 million (9.8% of revenue, adjusted for deferred compensation).
Cash and marketable securities at year-end totaled $203.9 million; $300 million credit facility undrawn.
Effective tax rate was a 9.4% benefit for Q4 and 13.0% expense for the year, including an $8.3 million benefit from Employee Retention Credits.
Outlook and guidance
Expects mid-single-digit revenue growth for 2026, with Q1 revenue guidance of $460–$465 million and sequential growth through the year.
2026 cost of services targeted at 86% of revenue; SG&A expected in the 9.5%-10.5% range, with a long-term goal of 8.5%-9.5%.
2026 effective tax rate projected at approximately 25%.
Net income expected to remain a strong proxy for cash flow from operations, excluding payroll accrual changes.
Latest events from Healthcare Services Group
- Q2 revenue reached $470.8M with margin gains, strong cash flow, and active share repurchases.HCSG
Q2 2026 - Dominates outsourced healthcare services with strong growth, financials, and client retention.HCSG
Investor presentation - Q1 2026 saw 3.4% revenue growth, 51% higher net income, and robust share repurchases.HCSG
Q1 2026 - Shareholders to vote on directors, pay, auditor, and equity plan amid strong growth and governance.HCSG
Proxy filing - Q3 revenue up 8.5% to $464.3M, net income $43M, aided by ERC refunds and strong segment growth.HCSG
Q3 2025 - Q3 2024 revenue and net income grew, with strong cash flow and reaffirmed guidance.HCSG
Q3 2024 - Q2 revenue rose 1.8% to $426.3M, but bad debt charges led to a net loss of $1.8M.HCSG
Q2 2024 - Q1 2025 saw record revenue, higher net income, and raised cash flow guidance.HCSG
Q1 2025 - Q4 revenue grew to $437.8M, but net income and margins fell; 2025 growth expected.HCSG
Q4 2024